GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tonghua Golden-horse Pharmaceutical Industry Co Ltd (SZSE:000766) » Definitions » Cyclically Adjusted PS Ratio

Tonghua Golden-horse Pharmaceutical Industry Co (SZSE:000766) Cyclically Adjusted PS Ratio : 10.97 (As of Jun. 06, 2024)


View and export this data going back to 1997. Start your Free Trial

What is Tonghua Golden-horse Pharmaceutical Industry Co Cyclically Adjusted PS Ratio?

As of today (2024-06-06), Tonghua Golden-horse Pharmaceutical Industry Co's current share price is ¥16.02. Tonghua Golden-horse Pharmaceutical Industry Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was ¥1.46. Tonghua Golden-horse Pharmaceutical Industry Co's Cyclically Adjusted PS Ratio for today is 10.97.

The historical rank and industry rank for Tonghua Golden-horse Pharmaceutical Industry Co's Cyclically Adjusted PS Ratio or its related term are showing as below:

SZSE:000766' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 2.92   Med: 12.42   Max: 51.37
Current: 11.19

During the past years, Tonghua Golden-horse Pharmaceutical Industry Co's highest Cyclically Adjusted PS Ratio was 51.37. The lowest was 2.92. And the median was 12.42.

SZSE:000766's Cyclically Adjusted PS Ratio is ranked worse than
94.35% of 744 companies
in the Drug Manufacturers industry
Industry Median: 2.05 vs SZSE:000766: 11.19

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Tonghua Golden-horse Pharmaceutical Industry Co's adjusted revenue per share data for the three months ended in Mar. 2024 was ¥0.306. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is ¥1.46 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Tonghua Golden-horse Pharmaceutical Industry Co Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Tonghua Golden-horse Pharmaceutical Industry Co's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tonghua Golden-horse Pharmaceutical Industry Co Cyclically Adjusted PS Ratio Chart

Tonghua Golden-horse Pharmaceutical Industry Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.77 3.15 4.03 4.02 13.87

Tonghua Golden-horse Pharmaceutical Industry Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.91 3.52 9.15 13.87 12.65

Competitive Comparison of Tonghua Golden-horse Pharmaceutical Industry Co's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Tonghua Golden-horse Pharmaceutical Industry Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tonghua Golden-horse Pharmaceutical Industry Co's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tonghua Golden-horse Pharmaceutical Industry Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Tonghua Golden-horse Pharmaceutical Industry Co's Cyclically Adjusted PS Ratio falls into.



Tonghua Golden-horse Pharmaceutical Industry Co Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Tonghua Golden-horse Pharmaceutical Industry Co's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=16.02/1.46
=10.97

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tonghua Golden-horse Pharmaceutical Industry Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Tonghua Golden-horse Pharmaceutical Industry Co's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.306/115.2271*115.2271
=0.306

Current CPI (Mar. 2024) = 115.2271.

Tonghua Golden-horse Pharmaceutical Industry Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 0.103 98.200 0.121
201409 0.138 98.900 0.161
201412 0.075 99.000 0.087
201503 0.076 99.900 0.088
201506 0.084 99.500 0.097
201509 0.091 100.500 0.104
201512 0.053 100.600 0.061
201603 0.134 102.200 0.151
201606 0.237 101.400 0.269
201609 0.222 102.400 0.250
201612 0.336 102.600 0.377
201703 0.204 103.200 0.228
201706 0.379 103.100 0.424
201709 0.366 104.100 0.405
201712 0.662 104.500 0.730
201803 0.373 105.300 0.408
201806 0.491 104.900 0.539
201809 0.530 106.600 0.573
201812 0.726 106.500 0.785
201903 0.424 107.700 0.454
201906 0.505 107.700 0.540
201909 0.487 109.800 0.511
201912 0.635 111.200 0.658
202003 0.157 112.300 0.161
202006 0.307 110.400 0.320
202009 0.341 111.700 0.352
202012 0.345 111.500 0.357
202103 0.395 112.662 0.404
202106 0.419 111.769 0.432
202109 0.306 112.215 0.314
202112 0.694 113.108 0.707
202203 0.371 114.335 0.374
202206 0.348 114.558 0.350
202209 0.331 115.339 0.331
202212 0.408 115.116 0.408
202303 0.319 115.116 0.319
202306 0.439 114.558 0.442
202309 0.324 115.339 0.324
202312 0.695 114.781 0.698
202403 0.306 115.227 0.306

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Tonghua Golden-horse Pharmaceutical Industry Co  (SZSE:000766) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Tonghua Golden-horse Pharmaceutical Industry Co Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Tonghua Golden-horse Pharmaceutical Industry Co's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Tonghua Golden-horse Pharmaceutical Industry Co (SZSE:000766) Business Description

Traded in Other Exchanges
N/A
Address
No. 999, Jinma Road, Erdaojiang District, Tonghua, Jilin, CHN, 134001
Tonghua Golden-horse Pharmaceutical Industry Co Ltd is a pharmaceutical company engaged in the manufacturing and sale of pharmaceutical products. It is a comprehensive pharmaceutical company integrating the production, sales, and research and development of pharmaceuticals. Tonghua's products mainly focus on rheumatism, bone diseases, digestion, tumors, and gynecology and distributing it mainly in the eastern part of China.
Executives
Wei Ying Jie Director
Zan Bao Shi Director
Wu Cheng Yu Directors, executives
Zhang De Ju Supervisors
Li Ju Supervisors
Feng Ran Director

Tonghua Golden-horse Pharmaceutical Industry Co (SZSE:000766) Headlines

No Headlines